Related Experiment Video
Updated: Mar 22, 2026

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
Published on: February 26, 2013
Warfarin continuation vs interruption during procedures of cardiac rhythm devices: A Meta-analysis of randomized
Huan Sun1, Beibei Du1, Xueyan Liu2
1Department of Cardiology, China-Japan Union Hospital of Jilin University, Changchun, China.
Insights
Continuing warfarin perioperatively during cardiac rhythm device implantation is safe and effective. Interruption with heparin bridging increases bleeding risk without affecting ischemic events in patients on chronic warfarin therapy.
Area of Science:
- Cardiology
- Pharmacology
- Medical Devices
Background:
- Patients on chronic anticoagulation require careful management during cardiac rhythm device (CRD) implantation.
- Warfarin and heparin bridging are common strategies for managing anticoagulation perioperatively.
- Uncertainty exists regarding the comparative safety and efficacy of these strategies.
Purpose of the Study:
- To compare the safety and efficacy of continuing warfarin versus heparin-bridging therapy during CRD implantation.
- To evaluate perioperative bleeding and ischemic risks associated with each anticoagulation strategy.
Main Methods:
- A meta-analysis of four randomized controlled trials (RCTs) involving 941 patients.
- Included studies focused on patients chronically treated with anticoagulants undergoing CRD implantation.
Main Results:
- Continuing warfarin perioperatively resulted in significantly lower bleeding risk compared to heparin bridging (RD -0.08, 95% CI -0.17 to 0.02, p<0.05).
- No significant difference in ischemic risk was observed between the two methods (RD 0, 95% CI -0.01 to 0.02, p=1.00).
Conclusions:
- Continuation of warfarin treatment is a safe and effective perioperative strategy for CRD implantation in patients on long-term warfarin therapy.
- Interruption of warfarin with heparin bridging may increase perioperative bleeding risk in this patient population.
Abstract:
To compare the safetyand efficacy of warfarin treatment continuation and heparin-bridging therapy during cardiac rhythm device (CRD) implantation in patients chronically treated with anticoagulants.We performed a search and analysis of peer-reviewed studies Four randomized controlled trials (RCTs)were included in our analysis with 941 patients. The bleeding risk in patients continuing warfarin perioperatively was lower than those interrupting warfarin and using a heparin-bridge (RD -0.08, 95% CI -0.17 to 0.02, p< 0.05). There was no significant difference in ischaemic risk between two methods (RD 0, 95% CI -0.01 to 0.02, p=1.00). Hence, in patients undergoing long-term warfarin therapy, continuation of warfarin treatment is a safe and efficacious perioperative strategy for during CRD implantations, while interruption of warfarin with a heparin bridge may increase the bleeding risk in these patients.
Related Concept Videos
Pulse rhythm
Conversely, an irregular pulse pattern is termed dysrhythmia, stemming from disruptions in cardiac...
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Venous Thrombosis III: Interprofessional Care
Cardiac Catheterization I: Pre-Procedure Overview
Cardiac Catheterization IV: Nursing Management
Anticoagulant Drugs: Low-Molecular-Weight Heparins

